tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

GEHCGE HealthCare

Health care · Medical Imaging · Nasdaq
Employees
54,000
Headquarters
Chicago, IL
CEO
Peter J. Arduini
Next results
around Feb 3, 2027
Compare with peers → Embed

9 paragraphs in Risk Factors of the 10-K filed Feb 4, 2026 with nothing like them in the 10-K filed Feb 13, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.

Compared with the Risk Factors in the latest 10-K of the other 59 Health care companies: a paragraph with at least half its words the same at another company is called similar, and the companies are listed under it. A paragraph most of them have is marked boilerplate. No line means no other company has one like it. This counts text; it does not say how serious a risk is.

This summary of risks is intended to provide an overview of the principal risks we face and should not be considered a substitute for a review of the more detailed risk factors discussed immediately following this summary.

Similar paragraph at 1 of 59 other Health care companies: BAX

•Our business is subject to the effects of global geopolitical and economic instability and public health crises.

Read in the 10-K ↗

•Our business strategy could be adversely affected if we are unable to successfully complete strategic transactions or manage our collaboration, joint venture, or similar arrangements.

Similar paragraph at 3 of 59 other Health care companies: CAH, DGX, STE

•Our business strategy includes substantial investment in R&D, with a focus on AI, cloud, edge computing, and software offerings. We cannot guarantee that these investments will generate new offerings, attract customers, or generate sufficient revenue.

Read in the 10-K ↗

•We manufacture and sell products that rely upon software and computer systems to operate properly and process and store confidential information. Our business could be adversely affected by increased cybersecurity requirements, vulnerabilities, threats, and more sophisticated and targeted cybercrimes, and our inability to obtain, maintain, protect, or effectively enforce our IP rights.

Read in the 10-K ↗

•Our existing indebtedness, and any additional indebtedness that we may incur, could have important consequences for our business.

Similar paragraph at 1 of 59 other Health care companies: VRTX
Read in the 10-K ↗

•the performance, capability, and integrity of third parties, including due to their financial instability or their compliance or regulatory failures;

Read in the 10-K ↗

•a failure to successfully enter new or emerging geographic or adjacent product markets, including as a result of pricing pressures from local and international competitors in those markets;

Read in the 10-K ↗

•inquiries and rulings by antitrust, foreign direct investment, or other regulatory bodies;

Read in the 10-K ↗

New in the latest 10-Q

2 paragraphs in the 10-Q filed Oct 28, 2026 with nothing like them in the 10-Q filed Jul 29, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.

Financial statements and notes

On October 5, 2026, we announced an agreement to acquire SOFIE Biosciences, a U.S.-based contract manufacturing organization for positron emission tomography (“PET”) radiopharmaceuticals, for a purchase price of $ 945 million to be paid in cash. The transaction is expected to close in the first half of 2027, subject to customary closing conditions, including regulatory approvals.

Read in the 10-Q ↗

Item 6

† Certain portions of this exhibit have been redacted pursuant to Item 601(b)(2)(ii) and Item 601(b)(10)(iv) of Regulation S-K, as applicable. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.

Read in the 10-Q ↗

The 10-Q's risk factors against the 10-K

Item 1A of the 10-Q filed Oct 28, 2026 against Item 1A of the 10-K filed Feb 4, 2026. A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed. Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed, Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal (cut words struck through, new words highlighted and underlined). Text on the page, not a score; each links to the filing at sec.gov.

What the 10-Q itself says about its risk factors:
There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Read in the 10-Q ↗

1 paragraph in the 10-Q's Item 1A, and none of them adds, rewords or quietly edits a paragraph of the 10-K's.

Work on GEHC in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/GEHC/export.csv") into a cell.